Seeking Alpha

Roche (RHHBY.PK) is offering $44.50/share (about $5.7B) in cash in a hostile bid to acquire...

Roche (RHHBY.PK) is offering $44.50/share (about $5.7B) in cash in a hostile bid to acquire DNA-tech Illumina (ILMN) - about an 18% premium over ILMN's Tuesday close, and a 64% premium to ILMN's price on Dec. 21, when takeover rumors began flying. Roche plans a conference call to discuss the deal tomorrow at 7 a.m.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|